[1] J P HENDRICK F U H. Molecular chaperone functions of heat-shock proteins.[J]. Annual review of biochemistry, 1993, 62: 349-384. DOI:
10.1146/annurev.bi.62.070193.002025[2] EDEN W, BROERE F, ZEE R. Heat Shock Proteins[C]. 1900: 0. DOI:
10.1007/978-3-7643-8550-7_94[3] SERENA CARRA . The growing world of small heat shock proteins: from structure to functions[J]. Cell Stress & Chaperones, 2017, 22 4: Pages 601-611. DOI:
10.1007/s12192-017-0787-8[4] ANASTASIA R. GOLOUDINA Carmen G Oleg N Demidov. Inhibition of HSP70: A challenging anti-cancer strategy[J]. Cancer letters, 2012, 325 2: Pages 117-124. DOI:
10.1016/j.canlet.2012.06.003[5] I KINDS-MüGGE F T. Increased expression of the M(r) 27,000 heat shock protein (hsp27) in in vitro differentiated normal human keratinocytes.[J]. Cell growth & differentiation: the molecular biology journal of the American Association for Cancer Research, 1994, 5 7: 777-781.
[6] S ROUSSEAU. Vascular endothelial growth factor (VEGF)-driven actin-based motility is mediated by VEGFR2 and requires concerted activation of stress-activated protein kinase 2 (SAPK2/p38) and geldanamycin-sensitive phosphorylation of focal adhesion kinase.[J]. The Journal of Biological Chemistry, 2000, 275 14: 10661-10672. DOI:
10.1074/jbc.275.14.10661[7] OLEG V EVGRAFOV. Mutant small heat-shock protein 27 causes axonal Charcot-Marie-Tooth disease and distal hereditary motor neuropathy[J]. Nature genetics, 2004, 36 6: 602-606. DOI:
10.1038/ng1354